Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Dorner

Showing results (21-30 of 136) with videos related to

Pageof 14
Sort By:
The Journal of Infectious Diseases|March 1, 1976
Escherichia coli enterotoxin: purification, partial characterization, and immunological observationsF Dorner, H Jaksche, W Stöckl
Biotechnology Therapeutics|January 1, 1991
Characterization of a vaccinia-derived recombinant HIV-1 gp160 candidate vaccine and its immunogenicity in chimpanzeesN Barrett, G Eder, F Dorner
Journal of Biotechnology|January 15, 1995
Purification of recombinant human coagulation factors II and IX and protein S expressed in recombinant Vaccinia virus-infected Vero cellsB Fischer, A Mitterer, F Dorner
Padiatrie Und Padologie|January 1, 1980
[The relationship of Coli strains and hemolysis in diarrhea]J Guggenbichler, A Weithaler, F Dorner
Zentralblatt Fur Veterinarmedizin. Reihe B. Journal of Veterinary Medicine. Series B|January 1, 1980
Immunity to Escherichia coli in piglets: the role of colostral antibodies directed against heat labile enterotoxin in experimental neonatal diarrhoeaF Dorner, P Mayer, R Leskova
Progress in Liver Diseases|January 1, 1986
Hepatitis B vaccineG Eder, J L McDonel, F Dorner
Developments in Biological Standardization|January 1, 1993
At what stage should virus inactivation be carried out?F Dorner, P N Barrett, J Eibl
Archives of Virology|May 8, 1998
Transient marker stabilisation: a general procedure to construct marker-free recombinant vaccinia virusF Scheiflinger, F Dorner, F G Falkner
Archives of Virology|January 1, 1996
Evaluation of the thymidine kinase (tk) locus as an insertion site in the highly attenuated vaccinia MVA strainF Scheiflinger, F G Falkner, F Dorner
Protein Expression and Purification|October 1, 1995
Requirements for optimal expression of secreted and nonsecreted recombinant proteins in vaccinia virus systemsM Pfleiderer, F G Falkner, F Dorner
Pageof 14

Showing results (21-30 of 136) with videos related to

Sort By:
Pageof 14
The Journal of Infectious Diseases|March 1, 1976
Escherichia coli enterotoxin: purification, partial characterization, and immunological observationsF Dorner, H Jaksche, W Stöckl
Biotechnology Therapeutics|January 1, 1991
Characterization of a vaccinia-derived recombinant HIV-1 gp160 candidate vaccine and its immunogenicity in chimpanzeesN Barrett, G Eder, F Dorner
Journal of Biotechnology|January 15, 1995
Purification of recombinant human coagulation factors II and IX and protein S expressed in recombinant Vaccinia virus-infected Vero cellsB Fischer, A Mitterer, F Dorner
Padiatrie Und Padologie|January 1, 1980
[The relationship of Coli strains and hemolysis in diarrhea]J Guggenbichler, A Weithaler, F Dorner
Zentralblatt Fur Veterinarmedizin. Reihe B. Journal of Veterinary Medicine. Series B|January 1, 1980
Immunity to Escherichia coli in piglets: the role of colostral antibodies directed against heat labile enterotoxin in experimental neonatal diarrhoeaF Dorner, P Mayer, R Leskova
Progress in Liver Diseases|January 1, 1986
Hepatitis B vaccineG Eder, J L McDonel, F Dorner
Developments in Biological Standardization|January 1, 1993
At what stage should virus inactivation be carried out?F Dorner, P N Barrett, J Eibl
Archives of Virology|May 8, 1998
Transient marker stabilisation: a general procedure to construct marker-free recombinant vaccinia virusF Scheiflinger, F Dorner, F G Falkner
Archives of Virology|January 1, 1996
Evaluation of the thymidine kinase (tk) locus as an insertion site in the highly attenuated vaccinia MVA strainF Scheiflinger, F G Falkner, F Dorner
Protein Expression and Purification|October 1, 1995
Requirements for optimal expression of secreted and nonsecreted recombinant proteins in vaccinia virus systemsM Pfleiderer, F G Falkner, F Dorner
Pageof 14